NIH Guide: Weekly Index for June 18, 2021

Funding Opportunities

• Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)
  (PA-21-264)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply. The first standard due date for the FOA is September 25, 2021. All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
  (PAR-21-240)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
  (PAR-21-241)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
  (PAR-21-242)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
  (PAR-21-243)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
  (PAS-21-245)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
  (RFA-AG-22-017)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): October 28, 2021
• Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)
  (RFA-AG-22-018)
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): October 28, 2021
• Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)
  (RFA-AI-20-069)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  Application Receipt Date(s): Not Applicable
• Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)
  (RFA-DA-22-009)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)
  (RFA-DA-22-017)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 12, 2021
• Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
  (RFA-HL-22-012)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): August 9, 2021, February 23, 2022, August 9, 2022, February 23, 2023, August 9, 2023, February 23, 2024